• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Select Medical Holdings Corporation Completes Spin-Off of Concentra

    11/25/24 5:30:00 PM ET
    $CON
    $SEM
    Medical Specialities
    Health Care
    Hospital/Nursing Management
    Health Care
    Get the next $CON alert in real time by email

    MECHANICSBURG, Pa., Nov. 25, 2024 /PRNewswire/ -- Select Medical Holdings Corporation ("Select Medical," "we," "us," or "our") (NYSE:SEM) today announced that we have completed our previously announced distribution (the "Distribution") of 104,093,503 shares of common stock of Concentra Group Holdings Parent, Inc. ("Concentra") (NYSE:CON) owned by Select Medical Corporation ("SMC"), a wholly owned subsidiary of Select Medical, representing approximately 81.7% of the outstanding shares of Concentra's common stock. After the completion of the Distribution, Select Medical no longer owns any shares of Concentra's common stock.

    The Distribution was made today to Select Medical's stockholders as of the close of business on the record date (the "Record Date") for the Distribution, November 18, 2024. The Distribution took place in the form of a pro rata common stock distribution to each of Select Medical's stockholder on the Record Date. Based on the shares of Select Medical's common stock outstanding as of the Record Date, Select Medical's stockholders received 0.806971 shares of Concentra's common stock for every share of Select Medical's common stock held as of the Record Date.

    No fractional shares of Concentra's common stock were distributed. Instead, Select Medical's stockholders will receive cash in lieu of any fraction of a share of Concentra's common stock that they otherwise would have received.

    On November 19, 2024, Select Medical made available an information statement to its stockholders on the Record Date, which included details on the Distribution. The information statement is posted under the Investor Relations tab on Select Medical's website at www.selectmedical.com/investor-relations/.

    J.P. Morgan and Goldman Sachs acted as financial advisors to Select Medical in connection with the Distribution. Dechert LLP acted as legal advisor to Select Medical in connection with the Distribution.

    About Select Medical

    Select Medical is one of the largest operators of critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States based on number of facilities. Select Medical's reportable segments include the critical illness recovery hospital segment, the rehabilitation hospital segment, the outpatient rehabilitation segment, and the Concentra segment. As of September 30, 2024, Select Medical operated 106 critical illness recovery hospitals in 29 states, 34 rehabilitation hospitals in 13 states, 1,925 outpatient rehabilitation clinics in 39 states and the District of Columbia, and 549 occupational health centers in 41 states. At September 30, 2024, Select Medical had operations in 46 states and the District of Columbia. Information about Select Medical is available at www.selectmedical.com.

    This press release may contain forward-looking statements based on current management expectations. Numerous factors, including those related to market conditions and those detailed from time-to-time in Select Medical's filings with the Securities and Exchange Commission, may cause results to differ materially from those anticipated in the forward-looking statements. Many of the factors that will determine Select Medical's future results are beyond the ability of Select Medical to control or predict. These statements are subject to risks and uncertainties and, therefore, actual results may differ materially. Readers should not place undue reliance on forward-looking statements, which reflect management's views only as of the date hereof. Select Medical undertakes no obligation to revise or update any forward-looking statements, or to make any other forward-looking statements, whether as a result of new information, future events or otherwise.

    Investor inquiries:

    Joel T. Veit

    Senior Vice President and Treasurer

    717-972-1100

    [email protected]

    Cision View original content:https://www.prnewswire.com/news-releases/select-medical-holdings-corporation-completes-spin-off-of-concentra-302315858.html

    SOURCE Select Medical Holdings Corporation

    Get the next $CON alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Q&A

    New
    • What significant corporate action did Select Medical Holdings Corporation announce?

      Select Medical completed the distribution of 104,093,503 shares of common stock of Concentra, representing 81.7% of Concentra's outstanding shares, to its stockholders.

    • When was the distribution of Concentra's shares completed?

      The distribution took place on November 25, 2024, to stockholders on the record date of November 18, 2024.

    • How many shares of Concentra's stock were distributed to Select Medical's stockholders for each share they owned?

      Stockholders received 0.806971 shares of Concentra's common stock for each share of Select Medical's stock they held as of the record date.

    • What will happen to fractional shares of Concentra's common stock that stockholders would have otherwise received?

      Select Medical stockholders will receive cash in lieu of any fractional shares of Concentra, as no fractional shares were distributed.

    • Who were the financial and legal advisors for Select Medical in this distribution?

      J.P. Morgan and Goldman Sachs acted as financial advisors, while Dechert LLP served as legal counsel to Select Medical during the distribution process.

    Recent Analyst Ratings for
    $CON
    $SEM

    CompanyDatePrice TargetRatingAnalyst
    Select Medical Holdings Corporation
    $SEM
    4/16/2025$25.00Outperform
    Mizuho
    Select Medical Holdings Corporation
    $SEM
    2/24/2025$23.00Hold → Buy
    The Benchmark Company
    Concentra Group Holdings Parent Inc.
    $CON
    12/16/2024$24.00Neutral → Buy
    BofA Securities
    Select Medical Holdings Corporation
    $SEM
    11/25/2024Buy → Hold
    The Benchmark Company
    Concentra Group Holdings Parent Inc.
    $CON
    10/7/2024$30.50 → $24.00Buy → Neutral
    BofA Securities
    Select Medical Holdings Corporation
    $SEM
    8/20/2024$42.00Buy
    BofA Securities
    Concentra Group Holdings Parent Inc.
    $CON
    8/20/2024$33.00Outperform
    RBC Capital Mkts
    Concentra Group Holdings Parent Inc.
    $CON
    8/19/2024Buy
    BofA Securities
    More analyst ratings

    $CON
    $SEM
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Khanuja Parvinderjit S. bought $315,420 worth of shares (21,000 units at $15.02), increasing direct ownership by 48% to 65,089 units (SEC Form 4)

      4 - SELECT MEDICAL HOLDINGS CORP (0001320414) (Issuer)

      5/6/25 6:21:53 PM ET
      $SEM
      Hospital/Nursing Management
      Health Care

    $CON
    $SEM
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Concentra® Announces Closing of Pivot Onsite Innovations Acquisition

      Concentra Group Holdings Parent, Inc. ("Concentra," "the Company," "we," "us," or "our") (NYSE:CON), the nation's largest provider of occupational health services, today announced the closing of the transaction to acquire Pivot Onsite Innovations from Athletico Physical Therapy. Pivot Onsite Innovations is a leader in the onsite health industry with over 200 onsite health clinics at employer locations in over 40 states. "We are very excited about the addition of Pivot Onsite Innovations to Concentra Onsite Health," said Matt DiCanio, Concentra's President and Chief Financial Officer. "This collaboration doubles the size of our growing Concentra Onsite Health operating segment and fully al

      6/2/25 9:00:00 AM ET
      $CON
      Medical Specialities
      Health Care
    • Concentra Expands in Chattanooga, Tennessee

      Concentra® (NYSE:CON) the nation's leader in occupational medicine, today announced the opening of a new medical center in Chattanooga, Tennessee. The medical center, Concentra Chattanooga Downtown is conveniently located at 1206 Broad Street, Suite 106, Chattanooga, Tennessee 37402. "We're excited to continue our expansion in eastern Tennessee," said Janet Cobb, MD, senior vice president of Concentra medical operations. "Expanding our footprint helps us to build stronger relationships with local employers and provide employees with additional access points to care." Concentra will provide work injury care, physical therapy, drug testing, DOT physical exams, pre-placement exams, and other

      5/19/25 8:20:00 AM ET
      $CON
      Medical Specialities
      Health Care
    • Concentra Group Holdings Parent, Inc. Announces Results For Its First Quarter Ended March 31, 2025, Cash Dividend, and Revised FY 2025 Guidance

      Concentra Group Holdings Parent, Inc. ("Concentra," the "Company," "we," "us," or "our") (NYSE:CON), the nation's largest provider of occupational health services, today announced results for its first quarter ended March 31, 2025, and the declaration of a cash dividend. "Concentra reported a solid start to 2025 with strong revenue and Adjusted EBITDA growth in the first quarter. With a deep understanding of patient and client needs and market dynamics, we continue to execute on key drivers of growth and deliver a comparative market advantage. Maintaining this focus ensures we continue to achieve our strategic business objectives for the year," said Keith Newton, Chief Executive Officer of

      5/7/25 4:30:00 PM ET
      $CON
      Medical Specialities
      Health Care